Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Study tests cheaper copycat drug for serious autoimmune disease

NCT ID NCT05716334

Summary

This study aimed to see if newer, more affordable 'biosimilar' versions of the drug rituximab work as well and are as safe as the original version for patients with two serious autoimmune diseases (GPA and MPA). Researchers followed 201 Canadian patients for two years, tracking their disease activity, side effects, and how long it took to get insurance approval for treatment. The goal was to provide real-world evidence to help doctors and patients choose between these treatment options.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANCA ASSOCIATED VASCULITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l'île-de-Montréal (CIUSSS NÎM) / Hôpital du Sacré-Coeur de Montréal

    Montreal, Quebec, Canada

  • Lawson Research Institute (Western University)

    London, Ontario, Canada

  • McGill University (Montreal General Hospital)

    Montreal, Quebec, H3G 1A4, Canada

  • Ottawa Hospital Research Institute (Ottawa University)

    Ottawa, Ontario, Canada

  • Sinai Health System (University of Toronto)

    Toronto, Ontario, Canada

  • St Joseph's Healthcare Hamilton (McMaster University)

    Hamilton, Ontario, Canada

  • University of Alberta

    Edmonton, Alberta, Canada

  • University of British Columbia (Vancouver Coastal Health Authority)

    Vancouver, British Columbia, Canada

  • University of Calgary

    Calgary, Alberta, Canada

Conditions

Explore the condition pages connected to this study.